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Abstract In a retrospective cohort study, we evaluated
whether improvements in nasal continuous positive airway
pressure (nCPAP) technology, particularly the introduction
of automatic adjustment of the nCPAP pressure (auto-
CPAP), have led to better acceptance and (long-term) com-
pliance in patients with obstructive sleep apnea syndrome
(OSAS) as compared to earlier reported data. Question-
naires were sent to 256 patients, who were referred to our
clinic for an overnight polysomnography from January
1997 to July 2005 and received nCPAP therapy for OSAS.
Of the 256 patients, 24 patients were unavailable for fol-
low-up. Of the remaining 232 patients, 58 patients (25%)
had discontinued therapy, while 174 patients (75%) were
still using nCPAP after 2 months to 8 years of follow-up.
One Hundred and thirty eight (79%) of these 174 patients
used nCPAP for at least 4 h/night during ¸ 5 nights/week,
82,1% of the conventional nCPAP (Wxed pressure CPAP)
group (n = 78) and 77,1% of the auto-CPAP group (n = 96).
Therefore, including the 58 failures, only 59.5% of patients
can be seen as compliant. There were no statistical diVer-
ences between the Wxed pressure CPAP and auto-CPAP
users, and between the compliant and non-compliant users
according to age, BMI, AHI and Epworth sleepiness scale
(ESS). Auto-CPAP patients used signiWcantly more cm
H2O. The long-term compliance of nCPAP therapy has
have increased only slightly since the introduction of the
Wxed pressure CPAP 25 years ago, in spite of many eVorts
to improve it. It seems that a plateau has been reached and
that it is unrealistic to aim at a substantially higher compli-
ance rate.
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Introduction
Obstructive sleep apnea syndrome (OSAS) is a clinically
deWned syndrome associating daytime hypersomnolence
and one or more of the following symptoms: severe snor-
ing, nocturnal respiratory arrest, repeated nocturnal awak-
ening, non-recuperative sleep and altered concentration,
due to repeated obstruction of the upper airway. An apnea-
hypopnea index (AHI) of more than Wve, obtained by over-
night polysomnography, accompanied by daytime symp-
toms is required for the diagnosis of sleep apnea syndrome.
[1] An apnea is a period of complete cessation of oronasal
airXow for a minimum of 10 s; periods of more than 30%
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more than 4% in ongoing SaO2, are hypopneas.
The prevalence of obstructive sleep apnea in middle-
aged people is 2% in women and 4% in men. [2] It has been
estimated that at least 80% of all moderate and severe
OSAS in the general population is likely to be missed. [3]
OSAS has adverse eVects on daytime quality such as
daytime sleepiness and diminished intellectual perfor-
mance. OSAS is of growing signiWcance because of its
increasingly recognized high incidence and association
with neurocognitive symptoms [4] and cardiovascular dis-
ease. [5] In severe OSAS, there is an increased risk to be
involved in traYc accidents. [6, 7] Therefore OSAS is not
only treated for its symptoms, but also with the aim to
reduce associated morbidity and mortality.
In 1981, nasal continuous positive airway pressure
(nCPAP), which acts as a pneumatic splint, was introduced
as treatment of OSAS and has been considered the gold
standard for treatment of severe OSAS since. [8] It is a safe
therapeutic option with few contraindications or serious
side eVects. [9] Unfortunately many patients experience
nCPAP therapy as obtrusive and the acceptance and (long-
term) compliance of nCPAP are at the most moderate. A
vast body of literature was published in the last two decades
on the subject of (long-term) compliance of nCPAP. [10–
23] Improvements in nCPAP technology, in particular the
introduction of automatic adjustments of the nCPAP pres-
sure throughout the night (auto-CPAP), [24–29] and other
attempts to enhance acceptance and compliance (positive
reinforcement, psychological/educational interventions,
heated humidiWcation) have been introduced. [30–34]
We were interested to see if these actions have led to
better acceptance, adherence and long-term compliance as
compared to earlier reported data. We acquired data on
(long-term) compliance and therapy failure. In this paper,
we report the results of this follow-up obtained by question-
naires, as well as the analysis of several parameters which
can predict compliance.
Methods
All patients with OSAS, as deWned previously, who were
oVered nCPAP between January 1997 and July 2005, were
included in the study. Patients with an AHI >30 were
oVered nCPAP as Wrst treatment. Patients with mild to
moderate OSAS (AHI <30) were also oVered alternative
treatments such as an oral device or surgery.
Polysomnography
From 1997 until 2001, patients were monitored with a digi-
tal CNS-sleep I/T-8 recorder (CNS Inc, Chanhassen, MN,
USA) during one night at the hospital. Since 2001, poly-
somnography was done using a digital Embla recorder
(Flaga Medical devices, Reykjavik, Iceland).
In both recorder types, polysomnography consisted of
electroencephalogram (derivations: CNS-sleep I/T-8: O1-
Cz; Embla: Fp2-C4/Fp1-C3), electrooculogram and sub-
mental electromyogram to record the sleep pattern. Tho-
racoabdominal excursions were registered by either
airinXated straps (Nellcor PB; model 5702-x, in the CNS-
sleep I/T-8), or by straps containing piezoelectric transduc-
ers (Embla). Pulse oximetry was used to monitor oxygen
saturation (SaO2) and heart rate. In addition ECG, move-
ments of the limbs and the intensity of snoring were
recorded. Nasal airXow was measured by a pressure sensor
with the Embla recorder only.
Electrodes and sensors were placed and equipment was
calibrated late in the afternoon. The system was switched
on and oV at 7.00 p.m. and 7.00 a.m. In case of the Embla
recorder all signals were recorded with DDD (digital sam-
pling, digital Wltering, digital storage) recording technol-
ogy. In both recorder types, storage was done on a
PCMCIA Xash card.
The following day, the data were downloaded to the
computer and analyzed by dedicated sleep software (CNS:
Sleep I/T software V1.70; Embla: Somnologica 2.0.2). In
both cases, the data were manually reviewed by an experi-
enced sleep investigator for Wnal analysis.
nCPAP therapy
Following the initial positive sleep study, patients were
again admitted to the hospital to titrate nCPAP therapy.
During two nights in the hospital, the optimal Wt of the
nCPAP mask (silicone-based nose or full face masks and
diVerent intranasal systems) was determined and the opti-
mal pressure of nCPAP therapy was established. From Jan-
uary 1997 until January 2002, the CPAP operating mode of
the BiPAP S/T-D® (Respironics INC, Murrysville, Penn-
sylvania, USA) was used. The patient’s optimal (Wxed)
level of continuous pressure (cm H20) was found by manual
titration by an experienced EEG technician during a night
session with polysomnography and video registration.
Since October 2002, auto-CPAP (AutoSet® T, ResMed
Limited, North Ride, Australia) was used exclusively. In
between there was an overlap period in which both modali-
ties were used.
A Wrst notice of compliance to and problems with accep-
tance of nCPAP was gathered during the Wrst two nights.
Within 1 week after titration, the Wrst evaluation took place
on the pulmonary outpatient clinic. Thereafter a test period
with nCPAP therapy in the home situation was started.
After the test period of about 4-5 weeks, the second evalua-
tion took place on the pulmonary department. The reports123
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were the experiences of the patients, after which a deWnitive
form of nCPAP therapy, mask and pressure was chosen.
After 4 months a Wnal appointment was made.
Questionnaires
All OSAS patients, who were oVered nCPAP, received
questionnaires including actual nCPAP usage, a visual ana-
logue scale for satisfaction of the therapy (a scale from
zero, not satisWed, to ten, very satisWed) and questions
about symptoms such as daytime sleepiness with the help
of the Epworth sleepiness scale (ESS). We deWned compli-
ance (or adherence) as minimally 4 h/night during Wve
nights per week of nCPAP use. Failure was deWned as a
refusal beforehand, withdrawal almost directly after the eli-
gibility tests without proper evaluation or failure to reduce
the AHI with nCPAP during the tests.
Statistics
All continuous variables were checked for their distribu-
tional characteristics. Whenever feasible (i.e., reasonably
normally distributed), mean and standard deviation were
used as statistics. DiVerences at baseline and after interven-
tion between Wxed pressure and auto-CPAP were tested by
means of a two-sample t test (based on a pooled standard
deviation or a Satterthwaite approximation in case of
unequal variances). Categorical variables were tested by
means of a Chi-square test.
Results 
From January 1997 to July 2005, 256 consecutive patients
were diagnosed with OSAS and oVered nCPAP therapy at
our hospital. Twenty-four (9.4%) patients were lost to fol-
low-up without any information available. Data could be
retrieved from 232 (90,6%) patients through returned ques-
tionnaires. The follow-up period ranged from 2 months to
8 years. Fifty-eight (25%) of these 232 patients (30 patients
had Wxed pressure CPAP, 28 patients had auto-CPAP)
failed to actually use the therapy. Five patients died before
evaluation could be obtained.
Of the evaluable 174 patients who used nCPAP, 78
patients were oVered Wxed pressure CPAP and 96 patients
auto-CPAP. There were 65 men (83.3%) and 13 women
(16,7%) in the Wxed pressure CPAP group and 75 men
(78,1%) and 21 women (21,9%) in the auto-CPAP group.
There was no diVerence in any of the baseline patient char-
acteristics between Wxed pressure CPAP and auto-CPAP
users (Table 1). Auto-CPAP patients used signiWcantly
more cm H2O (P < 0.0001).
The outcome parameters comparing the two groups are
shown in Table 2. No diVerence in the frequency of use of
nCPAP in terms of nights/week and hours/night was
observed between the two groups. Also in terms of
patients’ satisfaction, both methods were very similar. For
four patients, the number of nights a week and/or the
amount of time of nCPAP usage was unknown.
We deWned compliance as use of nCPAP at least 4 h/
night, ¸5 days/week. According to this deWnition, overall
138 (79%) of the 174 patients using nCPAP were compli-
ant, 82.1% of the Wxed pressure CPAP group and in 77.1%
of the auto-CPAP group. Therefore, including the 58 fail-
ures, only 59,5% of patients can be seen as compliant.
Except for satisfaction of nCPAP usage, no diVerences
were observed between the patients who were compliant
and the patients who were not (Table 3).
Discussion 
OSAS represents a relatively new disease entity, and is cur-
rently the most dynamic area in Otolaryngology/Head and
Neck Surgery, both with regard to diagnostic work-up and
therapy.
Treatment of OSAS is dependant on the severity of the
disease and starts primarily with lifestyle changes (weight
Table 1 Baseline patient characteristics
Type of CPAP P value
Fixed CPAP (n = 78) Auto-CPAP (n = 96)
Age 58.2 § 11.5 55.4 § 11.5 0.1111
BMI 33.0 § 7.9 33.1 § 7.0 0.9573
AHI 47.2 § 22.3 52.0 § 23.1 0.1814
ESS 5.6 § 4.5 7.1 § 5.1 0.0530
Table 2 Comparison of the use of Wxed pressure CPAP and auto-
CPAP in terms of nights/week and hours/night, as well according to
patients’ satisfaction (excluding failures)
F Wxed pressure CPAP, A auto-CPAP
Variable F/A N Mean SD Min. Max. T test p 
value
Nights/week F 76 6.4 1.4 2 7
A 96 6.3 1.4 1 7
DiV (1–2) ¡0.1 1.4 0.5710
Hours/night F 75 6.5 1.5 1.5 9
A 95 6.3 1.8 1 11
DiV (1–2) ¡0.1 1.7 0.6411
Satisfaction F 76 7.5 1,9 0 10
A 95 7.5 2,3 0 10
DiV (1–2) ¡0.1 2.1 0.8762123
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indicated. When complains persist after these, additional
therapies are needed. These can be subdivided into conser-
vative treatment (oral device or nCPAP), surgery (minimal
invasive to invasive) or combination of both.
NCPAP has become the “gold standard” treatment of
OSAS in the last decades. [35] In the pioneering phase of
management of OSAS this view was understandable since
uvulopalatopharyngoplasty (UPPP) was the almost exclu-
sive surgical alternative for the treatment of OSAS and
meta-analysis by Sher et al. in 1996 showed a success rate
of UPPP (in unselected patients) of only 41%[36].
To be successful, nCPAP therapy in OSAS has to be
accepted by the patient. Unfortunately, some patients sim-
ply refuse to use it upfront or later on, others try it but expe-
rience such serious problems such as nasal congestion and
dryness, rhinorrhoea, dryness in the mouth, mask discom-
fort, claustrophobia, aerophagia, air leakage and irritation
from device noise, that they have to give up. Other patients
use nCPAP only several days a week, and/or only a limited
number of hours per night sleep.
Various studies have analyzed compliance. However,
the results are not always consistent, mainly because of the
lack of common criteria. Furthermore, there are no precise
recommendations available concerning the necessary dura-
tion of daily and weekly use. In our study 58 (25 %) of 232
patients with suYcient information available, never started
nCPAP at all or stopped treatment (early). The compliance,
deWned as nCPAP use for minimally 4 h during Wve nights
per week, in the remaining 174 patients in our series, was
79% (82.1% for Wxed pressure CPAP vs. 77.1% for auto-
CPAP) as compared to earlier reported data, ranging from
46 to 89%. [10–23] Overall, only 59.5% of cases were suc-
cessful, taking the non-compliant cases and the 58 (25%)
failures together. Although it was to be expected that
patients with a higher AHI and ESS and lower required
pressure would be more compliant, no diVerence was
found. Also age and BMI played no role of signiWcance.
Patients with auto-CPAP used higher pressure levels
than patients with Wxed pressure CPAP. A reason for this
statistical diVerence is that while titrating for Wxed pressure
CPAP with the auto-CPAP, the choice for the lowest pres-
sure needed is often taken, because to minimize side eVects
too much pressure while not needed has to be avoided.
A limitation of our study is that the use of nCPAP in our
series was estimated by the patient and not recorded by a
clock-time counter, and it can therefore not be excluded
that the actual use is even lower; discrepancies between
subjective and objective duration and frequency of nCPAP
use have been reported. [15] When looking back at
2 decades (1986–now) [10–23] of all reported series on
nCPAP use, the conclusion is that in spite of many
improvements in the machinery, adjustment, intensive sup-
port, and all attempts (positive reinforcement, psychologi-
cal/educational interventions, heated humidiWcation) to
increase compliance otherwise, the overall compliance has
only improved marginally, if at all.
Currently, we are witnessing an increasing awareness
that an exciting new era in OSAS treatment is dawning.
Besides the disappointing compliance rates, the use of
nCPAP therapy does not change the anatomy of the upper
airway and therefore patients remain dependant, lifelong. In
particular for young patients, the prospect to use nCPAP
lifelong is unattractive and with increasing frequency
patients ask for surgical alternatives with acceptable suc-
cess rates.
Also in the light of failure rates for nCPAP therapy, it is
hard to maintain that nCPAP should always be preferred
above other treatments. Success rates of UPPP in well-
selected patients (obstruction on retro palatal level only)
currently reach 70–80%, as compared to the low 40% in
earlier meta-analyses in non-selected patients. [37,38] In
patients with obstruction at the retrolingual level, compara-
ble surgical success rates of hyoid suspension have been
reported in well-selected patients. [39, 40] Many other sur-
gical and non-surgical approaches are being explored as
stand-alone therapy, or in combination. [41, 42] Therefore,
a gradual shift can be expected to take place to alternatives
to nCPAP, being a combination of surgery, lifestyle altera-
tions and if possible positional therapy, [43, 44] in well-
Table 3 Comparison of parameters between ‘compliant’ and ‘non-
compliant’ (excluding failures)
C compliant patients, NC non compliant patients, H2O cm H2O
pressure
Variable C/NC N Mean SD Min Max t test p 
value
Age C 138 56.9 11.6 27 86
NC 33 55.3 11.7 34 79
DiV (1–2) ¡1.6 11.6 0.4898
BMI C 138 32.9 7.2 21.9 75.8
NC 32 34.2 8.4 22.3 54.6
DiV (1–2) 1.3 7.4 0.3777
AHI C 131 51 21.7 9.7 123
NC 31 47.1 27.3 5 98
DiV (1–2) ¡3.9 22.9 0.3974
H2O C 137 8.9 2.4 3 15.5
NC 33 8.6 2.6 4 15
DiV (1–2) ¡0.2 2.5 0.6330
ESS C 136 6.1 4.9 0 23
NC 33 7.6 4.6 0 16
DiV (1–2) 1.5 4.9 0.1083
Satisfaction C 137 8 1.7 1 10
NC 33 5.7 2.6 0 10
DiV (1–2) ¡2.2 1.9 <0.0001123
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those patients will still be in reserve in case of failure.
In conclusion, the long-term compliance of nCPAP ther-
apy has increased only slightly since the introduction of
nCPAP 25 years ago, in spite of many eVorts to improve it.
It seems that a plateau has been reached and that it is unre-
alistic to expect substantially higher compliance rates. The
great challenge for the ENT-community is to accept the
responsibility to endeavour to develop viable alternatives to
nCPAP therapy, both for the high percentage of patients
who are nCPAP failures as well as for primary treatment.
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